DFIN to Participate in Upcoming Investor Conferences
Get Alerts DFIN Hot Sheet
Join SI Premium – FREE
- 19th Annual Needham Technology, Media, & Consumer Conference –
Tuesday, May 14, 2024 inNew York City .Dan Leib , CEO, andDave Gardella , CFO will participate in a fireside chat at11:45 AM EST and host investor meetings. - 24th Annual B. Riley Securities Institutional Investor Conference –
Thursday, May 23, 2024 inBeverly Hills, California .Dan Leib , CEO, andDave Gardella , CFO will participate in a roundtable discussion and host investor meetings. - Wolfe Research Small and Mid-Cap Conference –
Wednesday, June 5, 2024 inNew York City .Dave Gardella , CFO, will host investor meetings.
A link to the live webcast of the Needham fireside chat will be available on the Company's Investor Relations home page at investor.dfinsolutions.com. For those unable to listen live, a webcast replay will be archived on DFIN's Investor Relations website after the call.
About Donnelley Financial Solutions (DFIN)
FIN is a leading global provider of innovative software and technology-enabled financial regulatory and compliance solutions. We provide domain expertise, enterprise software and data analytics for every stage of our clients' business and investment lifecycles. Markets fluctuate, regulations evolve, technology advances, and through it all, DFIN delivers confidence with the right solutions in moments that matter. Learn about DFIN's end-to-end risk and compliance solutions online at DFINsolutions.com or you can also follow us on X (formerly Twitter) @DFINSolutions or on LinkedIn.
View original content:https://www.prnewswire.com/news-releases/dfin-to-participate-in-upcoming-investor-conferences-302137192.html
SOURCE Donnelley Financial LLC
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Galibra Neuroscience Receives FDA Orphan Drug and Rare Pediatric Disease Designations for SSADH Deficiency Gene Therapy
- Every enduring field of medicine is built on clinical architecture.
- Moderna Receives U.S. FDA Approval for Influenza Vaccine mFLUSIVA
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Needham & Company, B. Riley, TwitterSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share